Your browser doesn't support javascript.
loading
Results of the COVID-19 mental health international for the health professionals (COMET-HP) study: depression, suicidal tendencies and conspiracism.
N Fountoulakis, Konstantinos; N Karakatsoulis, Grigorios; Abraham, Seri; Adorjan, Kristina; Ahmed, Helal Uddin; Alarcón, Renato D; Arai, Kiyomi; Auwal, Sani Salihu; Bobes, Julio; Bobes-Bascaran, Teresa; Bourgin-Duchesnay, Julie; Bredicean, Cristina Ana; Bukelskis, Laurynas; Burkadze, Akaki; Cabrera Abud, Indira Indiana; Castilla-Puentes, Ruby; Cetkovich, Marcelo; Colon-Rivera, Hector; Corral, Ricardo; Cortez-Vergara, Carla; Crepin, Piirika; de Berardis, Domenico; Zamora Delgado, Sergio; de Lucena, David; de Sousa, Avinash; di Stefano, Ramona; Dodd, Seetal; Elek, Livia Priyanka; Elissa, Anna; Erdelyi-Hamza, Berta; Erzin, Gamze; Etchevers, Martin J; Falkai, Peter; Farcas, Adriana; Fedotov, Ilya; Filatova, Viktoriia; Fountoulakis, Nikolaos K; Frankova, Iryna; Franza, Francesco; Frias, Pedro; Galako, Tatiana; Garay, Cristian J; Garcia-Álvarez, Leticia; García-Portilla, Paz; Gonda, Xenia; Gondek, Tomasz M; Morera González, Daniela; Gould, Hilary; Grandinetti, Paolo; Grau, Arturo.
Affiliation
  • N Fountoulakis K; 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki Greece, Thessaloniki, Greece.
  • N Karakatsoulis G; 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki Greece, Thessaloniki, Greece. gregkarakatsoulis@gmail.com.
  • Abraham S; Pennine Care NHS Foundation Trust, Ashton-under-Lyne, UK.
  • Adorjan K; Manchester Metropolitan University, Manchester, UK.
  • Ahmed HU; Core Psychiatry Training, Health Education England North West, Manchester, UK.
  • Alarcón RD; Department of Psychiatry, Ludiwig-Maximilians-University, Munich, Germany.
  • Arai K; Child Adolescent and Family Psychiatry, National Institute of Mental Health, Dhaka, Bangladesh.
  • Auwal SS; Section of Psychiatry and Mental Health, Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado, Lima, Peru.
  • Bobes J; Department of Psychiatry and Psychology, Mayo Clinic School of Medicine, Rochester, MN, USA.
  • Bobes-Bascaran T; School of Medicine and Health Science, Institute of Health Science Shinshu University, Matsumoto, Japan.
  • Bourgin-Duchesnay J; Department of Psychiatry, Bayero University, Kano, Nigeria.
  • Bredicean CA; Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Bukelskis L; Psychiatry Area, Department of Medicine, University of Oviedo, ISPA, INEUROPA. CIBERSAM, Oviedo, Spain.
  • Burkadze A; Department of Psychiatry, Hospital Universitario Central de Asturias, ISPA, INEUROPA. CIBERSAM, Oviedo, Spain.
  • Cabrera Abud II; Mental Health Center of La Corredoria, ISPA, INEUROPA. CIBERSAM, Oviedo, Spain.
  • Castilla-Puentes R; Department of Psychology, University of Oviedo, ISPA, INEUROPA. CIBERSAM, Oviedo, Spain.
  • Cetkovich M; Division of Child and Adolescent Psychiatry, Department of Psychiatry, Groupe Hospitalier Nord Essonne, Orsay, France.
  • Colon-Rivera H; Department of Neuroscience, Discipline of Psychiatry, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
  • Corral R; Clinic of Psychiatry, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
  • Cortez-Vergara C; Mental Hub, Tbilisi, Georgia.
  • Crepin P; NGO Healthcare Research and Quality Agency, Tbilisi, Georgia.
  • de Berardis D; Hospital San Juan de Dios Hospital, Guadalajara, Mexico.
  • Zamora Delgado S; Janssen Research and Development, Johnson and Johnson, American Society of Hispanic Psychiatry and WARMI Women Mental Health, Cincinnati, OH, USA.
  • de Lucena D; Institute of Translational and Cognitive Neuroscience (INCyT), INECO Foundation, Favaloro University, Buenos Aires, Argentina.
  • de Sousa A; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.
  • di Stefano R; APM Board Certified in General Psychiatry and Neurology, Addiction Psychiatry, and Addiction Medicine, UPMC, DDAP, Philadelphia, USA.
  • Dodd S; Department of Teaching and Research, Hospital Borda, Buenos Aires, Argentina.
  • Elek LP; University of Buenos Aires, Buenos Aires, Argentina.
  • Elissa A; Universidad Peruana Cayetano Heredia, Clínica AngloAmericana, Lima, Perú.
  • Erdelyi-Hamza B; Sanitaire and Social Union for Accompaniment and Prevention, Center of Ambulatory Psychiatry of Narbonne and Lezigan, Narbonne, France.
  • Erzin G; Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital "G. Mazzini", ASL Teramo, Teramo, Italy.
  • Etchevers MJ; School of Nursing, University of L'Aquila, L'Aquila, Italy.
  • Falkai P; Department of Neuroscience and Imaging, School of Psychiatry, University of Chieti, Chieti, Italy.
  • Farcas A; Child and Adolescent Psychiatry Department, Hospital Luis Calvo Mackenna, Santiago, Chile.
  • Fedotov I; Departamento de Fisiología E Farmacología, Universidade Federal Do Ceará, Fortaleza, Ceará, Brazil.
  • Filatova V; Department of Psychiatry, Lokmanya Tilak Municipal Medical College, Mumbai, India.
  • Fountoulakis NK; Desousa Foundation, Mumbai, India.
  • Frankova I; Department of Biotechnological and Applied Clinical Sciences, Section of Psychiatry, University of L'Aquila, L'Aquila, Italy.
  • Franza F; IMPACT-the Institute for Mental and Physical Health and Clinical Translation, Deakin University, School of Medicine, Barwon Health, Geelong, Australia.
  • Frias P; Orygen The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia.
  • Galako T; University Hospital Geelong, Barwon Health, Geelong, VIC, Australia.
  • Garay CJ; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
  • Garcia-Álvarez L; Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia.
  • García-Portilla P; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
  • Gonda X; Psychiatry Department, Ankara Diskapi Training and Research Hospital, Ankara, Turkey.
  • Gondek TM; Faculty of Psychology, University of Buenos Aires (UBA), Buenos Aires, Argentina.
  • Morera González D; Department of Psychiatry, Ludiwig-Maximilians-University, Munich, Germany.
  • Gould H; Centre of Neuroscience, Queen's University, Kingston, ON, Canada.
  • Grandinetti P; Department of Psychiatry and Narcology, Ryazan State Medical University N.a. Academician I.P. Pavlov, Ryazan, Russia.
  • Grau A; State Budgetary Institution of the Rostov Region "Psychoneurological Dispensary", Rostov-On-Don, Russia.
Soc Psychiatry Psychiatr Epidemiol ; 58(9): 1387-1410, 2023 Sep.
Article in En | MEDLINE | ID: mdl-36867224
ABSTRACT

INTRODUCTION:

The current study aimed to investigate the rates of anxiety, clinical depression, and suicidality and their changes in health professionals during the COVID-19 outbreak. MATERIALS AND

METHODS:

The data came from the larger COMET-G study. The study sample includes 12,792 health professionals from 40 countries (62.40% women aged 39.76 ± 11.70; 36.81% men aged 35.91 ± 11.00 and 0.78% non-binary gender aged 35.15 ± 13.03). Distress and clinical depression were identified with the use of a previously developed cut-off and algorithm, respectively. STATISTICAL

ANALYSIS:

Descriptive statistics were calculated. Chi-square tests, multiple forward stepwise linear regression analyses, and Factorial Analysis of Variance (ANOVA) tested relations among variables.

RESULTS:

Clinical depression was detected in 13.16% with male doctors and 'non-binary genders' having the lowest rates (7.89 and 5.88% respectively) and 'non-binary gender' nurses and administrative staff had the highest (37.50%); distress was present in 15.19%. A significant percentage reported a deterioration in mental state, family dynamics, and everyday lifestyle. Persons with a history of mental disorders had higher rates of current depression (24.64% vs. 9.62%; p < 0.0001). Suicidal tendencies were at least doubled in terms of RASS scores. Approximately one-third of participants were accepting (at least to a moderate degree) a non-bizarre conspiracy. The highest Relative Risk (RR) to develop clinical depression was associated with a history of Bipolar disorder (RR = 4.23).

CONCLUSIONS:

The current study reported findings in health care professionals similar in magnitude and quality to those reported earlier in the general population although rates of clinical depression, suicidal tendencies, and adherence to conspiracy theories were much lower. However, the general model of factors interplay seems to be the same and this could be of practical utility since many of these factors are modifiable.
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Type of study: Etiology_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Type of study: Etiology_studies / Prognostic_studies Limits: Female / Humans / Male Language: En Year: 2023 Type: Article